From September 25 to 26, 2013, an assessment on safety standardization compliance to Chongqing Daxin Pharmaceutical was carried out by Chongqing safety standardization review Group, after a two-day review, Daxin Pharmaceutical passed the national safety standardization compliance secondary level assessment.
